跳至主要内容
临床试验/IRCT20141009019470N85
IRCT20141009019470N85已完成2 期

Comparison of prevalence of nausea and vomiting after laparascopic cholecystectomy in case of pretreatment with Haloperidol and Ondansetron

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Age 18--60 years old
  • Patients undergoing laparoscopy cholecystectomy under general anesthesia
  • Cholelithiasis
  • Chronic cholecystitis
  • Cholecystic polyp

排除标准

  • Underlying medical condition that is currently not under control
  • History of allergy to drugs or use of alcohol;
  • History of glaucoma
  • Bone marrow depression
  • Severe liver disease
  • Obstructive bowel disease
  • History of prostate disease
  • History of cardiac arrhythmia
  • History of respiratory failure or respiratory distress
  • Taking antidepressants
  • History of allergy to haloperidol or ondansetron
  • Breast feeding patients
  • Digestive diseases, kidney and hematology
  • History of dizziness or motion
  • Use an anti-nausea and vomiting agent within 24 hours before the surgery
  • Anxiety disorders,Restlessness, loss in time and place
  • Confusion, tremor, chills, seizure, tinnitus
  • History of Bradycardia
  • Reduced cardiac function
  • Low blood pressure
  • Surgery takes more than an hour.
  • Opium addiction

研究者

相似试验

Comparison of prevalence of nausea and vomiting... | 临床试验